
Vera Therapeutics Chief Regulatory Officer William D. Turner Reports Sale of Common Shares

I'm PortAI, I can summarize articles.
William D. Turner, Chief Regulatory Officer of Vera Therapeutics Inc., reported the sale of common shares of the company. This information was published via EDGAR by Vera Therapeutics and is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

